Regeneron’s Acquisition of Decibel Therapeutics

Wachtell Lipton advised Regeneron, and Wilmer Cutler advised Decibel.Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Decibel Therapeutics, Inc. (NASDAQ: DBTX) announced a definitive agreement for the acquisition…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now